Patient info Open main menu

Losartan Potassium/hydrochlorothiazide 50/12.5 mg film-coated tablets – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
50/12.5 mg
Contains active substances:

Patient leaflet - Losartan Potassium/hydrochlorothiazide 50/12.5 mg film-coated tablets

1. What Losartan HCT tablets are and what they are used for

Losartan HCT tablets are a combination of an angiotensin II receptor antagonist (losartan) and a diuretic (hydrochlorothiazide). Angiotensin II is a substance produced in the body which binds to receptors in blood vessels, causing them to tighten. This results in an increase in blood pressure. Losartan prevents the binding of angiotensin II to these receptors, causing the blood vessels to relax which in turn lowers the blood pressure. Hydrochlorothiazide works by making the kidneys pass more water and salt. This also helps to reduce blood pressure.

Losartan HCT tablets are indicated for the treatment of essential hypertension (high blood pressure).

2. What you need to know before you take Losartan HCT tablets

Do not take Losartan HCT tablets if you

  • are allergic to losartan, hydrochlorothiazide or to any of the other ingredients of this medicine (listed in section 6)
  • are allergic (hypersensitive) to other sulfonamide-derived substances (e. g. other thiazides, some antibacterial drugs such as co-trimoxazole, ask your doctor if you are not sure)
  • have severely impaired liver function
  • are more than 3 months pregnant (it is also better to avoid Losartan HCT tablets in early pregnancy – see pregnancy section)
  • have severely impaired kidney function or your kidneys are not producing any urine
  • have low potassium, low sodium or high calcium levels which cannot be corrected by treatment
  • are suffering from gout
  • have diabetes or impaired kidney function and you are treated with a blood pressure lowering medicine containing aliskiren.

Warnings and precautions

Talk to your doctor if you experience abdominal pain, nausea, vomiting or diarrhoea after taking Losartan HCT tablets. Your doctor will decide on further treatment. Do not stop taking Losartan HCT tablets on your own.

Talk to your doctor, pharmacist or nurse before taking Losartan HCT.

You must tell your doctor if you think you are (or might become) pregnant. Losartan HCT tablets are not recommended in early pregnancy, and must not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used at that stage (see pregnancy section).

It is important to tell your doctor before taking Losartan HCT tablets if you:

  • have previously suffered from swelling of the face, lips, throat or tongue
  • take diuretics (water pills)
  • are on a salt-restricted diet
  • have or have had severe vomiting and/or diarrhoea
  • have heart failure
  • your liver function is impaired (see section 2 “Do not take Losartan HCT”)
  • have narrow arteries to your kidneys (renal artery stenosis) or only have one functioning kidney, or you have recently had a kidney transplant
  • have narrowing of the arteries (atherosclerosis), angina pectoris (chest pain due to poor heart function)
  • have ‘aortic or mitral valve stenosis’ (narrowing of the valves of the heart) or ‘hypertrophic cardiomyopathy’ (a disease causing thickening of heart muscle)
  • are diabetic
  • have had gout
  • have or have had an allergic condition, asthma or a condition that causes joint pain, skin rashes and fever (systemic lupus erythematosus)
  • have had skin cancer or if you develop an unexpected skin lesion during the treatment. Treatment with hydrochlorothiazide, particularly long term use with high doses, may increase the risk of some types of skin and lip cancer (non-melanoma skin cancer). Protect your skin from sun exposure and UV rays while taking Losartan HCT tablets
  • experience a decrease in vision or eye pain. These could be symptoms of fluid accumulation in the vascular layer of the eye (choroidal effusion) or an increase of pressure in your eye and can happen within hours to weeks of taking Losartan HCT tablets. This can lead to permanent vision loss if not treated. If you earlier have had a penicillin or sulfonamide allergy, you can be at higher risk of developing this
  • have experienced breathing or lung problems (including inflammation or fluid in the lungs) following hydrochlorothiazide intake in the past. If you develop any severe shortness of breath or difficulty breathing after taking Losartan HCT tablets, seek medical attention immediately
  • have high calcium or low potassium levels or you are on a low potassium diet
  • need to have an anaesthetic (even at the dentist) or before surgery, or if you are going to have tests to check your parathyroid function, you must tell the doctor or medical staff that you are taking Losartan HCT tablets
  • suffer from primary hyperaldosteronism (a syndrome associated with increased secretion of the hormone aldosterone by the adrenal gland, caused by an abnormality within the gland)
  • are taking any of the following medicines used to treat high blood pressure:

    • an ACE-inhibitor (for example enalapril, lisinopril, ramipril), in particular if you have diabetes-related kidney problems.
    • aliskiren
  • are taking other medicines that may increase serum potassium (section 2 “Other medicines and Losartan HCT”).

Your doctor may check your kidney function, blood pressure and the amount of electrolytes (e.g. potassium) in your blood at regular intervals.

See also information under the heading “Do not take Losartan HCT tablets if you”.

Children and adolescents

There is no experience with the use of Losartan HCT tablets in children. Therefore Losartan HCT tablets should not be given to children.

Other medicines and Losartan HCT tablets

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Tell your doctor if you are taking potassium supplements, potassium-containing salt substitutes, potassium-sparing medicines, or other medicines that may increase serum potassium (e.g. trimethoprim-containing medicines), as the combination with Losartan HCT is not advisable.

Diuretic agents such as the hydrochlorothiazide contained in Losartan HCT tablets may interact with other medicines.

Preparations containing lithium should not be taken with Losartan HCT tablets without close supervision by your doctor.

Special precautionary measures (e.g. blood tests) may be appropriate if you take other diuretics (“water tablets”), some laxatives, glycyrrhizin (found in liquorice), medicines for the treatment of gout, medicines to control heart rhythm or for diabetes (oral agents or insulins).

It is also important for your doctor to know if you are taking:

  • other medicines to reduce your blood pressure
  • steroids
  • medicines to treat cancer
  • painkillers
  • drugs for treatment of infections, including fungal infections
  • arthritis medicines
  • resins used for high cholesterol, such as colestyramine
  • medicines which relax your muscles
  • sleeping tablets
  • opioid medicines such as morphine
  • “pressor amines” such as adrenaline or other drugs from the same group
  • oral agents for diabetes or insulins
  • anticholinergic agents (e.g. atropine, biperiden)
  • antipsychotics
  • antidepressants
  • carbamazepine.

Your doctor may need to change your dose and/or to take other precautions.

If you are taking an ACE-inhibitor or aliskiren (see also information under the headings “Do not take Losartan HCT” and “Warnings and Precautions”).

Please also inform your doctor you are taking Losartan HCT tablets if you will be undergoing a radiographic procedure and will be given iodine contrast media.

Losartan HCT tablets with food and drink and alcohol

You are advised not to drink alcohol whilst taking these tablets: alcohol and Losartan HCT tablets may increase each other’s effects.

Dietary salt in excessive quantities may counteract the effect of Losartan HCT tablets.

Losartan HCT tablets may be taken with or without food.

Grapefruit juice should be avoided while taking Losartan HCT tablets.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy

You must tell your doctor if you think you are (or might become) pregnant. Your doctor will normally advise you to stop taking Losartan HCT tablets before you become pregnant or as soon as you know you are pregnant and will advise you to take another medicine instead of Losartan HCT tablets. Losartan HCT tablets are not recommended during pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.

Breastfeeding

Tell your doctor if you are breast-feeding or about to start breast-feeding. Losartan HCT tablets are not recommended for mothers who are breast-feeding, and your doctor may choose another treatment for you if you wish to breast-feed.

Use in elderly patients

Losartan HCT tablets work equally well in and are equally well tolerated by most older and younger adult patients. Most older patients require the same dose as younger patients.

Driving and using machines

When you begin treatment with this medication, you should not perform tasks which may require special attention (for example, driving a car or operating dangerous machinery) until you know how you tolerate your medicine.

Losartan HCT tablets contain sodium

This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium-free’.

3. How to take Losartan HCT tablets

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Your doctor will decide on the appropriate dose of Losartan HCT tablets depending on your condition and whether you are taking other medicines. It is important to continue taking Losartan HCT tablets for as long as your doctor prescribes them in order to maintain smooth control of your blood pressure.

High Blood Pressure

The recommended usual dose of Losartan HCT tablets for most patients with high blood pressure is 1 tablet of Losartan HCT 50mg/12.5mg per day to control blood pressure over the 24-hour period. This can be increased to 2 tablets once daily of losartan/hydrochlorothiazide 50mg/12.5mg film-coated tablets or changed to 1 tablet daily of losartan/hydrochlorothiazide 100mg/25mg film-coated tablets (a stronger strength) per day. The maximum daily dose is 2 tablets per day of losartan/hydrochlorothiazide 50mg/12.5mg film-coated tablets or 1 tablet daily of losartan/hydrochlorothiazide 100mg/25mg film-coated tablets.

Administration

The tablets should be swallowed whole with a glass of water.

If you take more Losartan HCT tablets than you should

In case of an overdose, contact your doctor immediately so that medical attention may be given promptly. An overdose can cause a drop in blood pressure, palpitations, slow pulse, changes in blood composition and dehydration.

If you forget to take Losartan HCT tablets

Try to take Losartan HCT tablets daily as prescribed. However, if you do miss a dose do not take a double dose to make up for a forgotten dose.

Just resume your usual schedule.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you experience the following, stop taking Losartan HCT tablets and tell your doctor immediately or go to the casualty department of your nearest hospital:

  • A severe allergic reaction (rash, itching, swelling of the face, lips, mouth or throat that may cause difficulty in swallowing or breathing).

This is a serious but rare side effect, which affects more than 1 out of 10,000 patients but fewer than 1 out of 1,000 patients. You may need urgent medical attention or hospitalisation.

Other side effects that may occur:

Common (may affect up to 1 in 10 people):

  • Cough, upper airway infection, congestion in the nose, sinusitis, sinus disorder
  • Diarrhoea, abdominal pain, nausea, indigestion
  • Muscle pain or cramps, leg pain, back pain
  • Insomnia, headache, dizziness
  • Weakness, tiredness, chest pain
  • Increased potassium levels (which can cause an abnormal heart rhythm), decreased haemoglobin levels
  • Changes in kidney function including kidney failure
  • Low blood sugar (hypoglycaemia).

Uncommon (may affect up to 1 in 100 people):

  • Anaemia, red or brownish spots on the skin (sometimes especially on the feet, legs, arms and buttocks, with joint pain, swelling of the hands and feet and stomach pain), bruising, reduction in white blood cells, clotting problems, reduced number of platelets
  • Loss of appetite, increased uric acid levels or frank gout, increased blood sugar levels, abnormal blood electrolyte levels
  • Anxiety, nervousness, panic disorder (recurring panic attacks), confusion, depression, abnormal dreams, sleep disorders, sleepiness, memory impairment
  • Pins and needles or similar sensations, pain in the extremities, trembling, migraine, fainting
  • Blurred vision, burning or stinging in the eyes, conjunctivitis, worsening eyesight, seeing things in yellow
  • Ringing, buzzing, roaring or clicking in the ears, vertigo
  • Low blood pressure, which may be associated with changes in posture (feeling light-headed or weak when you stand up), angina (chest pain), abnormal heartbeat, cerebrovascular accident (TIA, “mini-stroke”), heart attack, palpitations
  • Inflammation of blood vessels, which is often associated with a skin rash or bruising
  • Sore throat, breathlessness, bronchitis, pneumonia, water on the lungs (which causes difficulty breathing), nosebleed, runny nose, congestion
  • Constipation, obstipation, wind, stomach upsets, stomach spasms, vomiting, dry mouth, inflammation of a salivary gland, toothache
  • Jaundice (yellowing of the eyes and skin), inflammation of the pancreas
  • Hives, itching, inflammation of the skin, rash, redness of the skin, sensitivity to light, dry skin, flushing, sweating, hair loss
  • Pain in the arms, shoulders, hips, knees or other joints, joint swelling, stiffness, muscle weakness
  • Frequent urination including at night, abnormal kidney function including inflammation of the kidneys, urinary infection, sugar in the urine
  • Decreased sexual appetite, impotence
  • Swelling of the face, localised swelling (oedema), fever.

Rare (may affect up to 1 in 1,000 people):

  • Hepatitis (inflammation of the liver), abnormal liver function tests
  • Intestinal angioedema: a swelling in the gut presenting with symptoms like abdominal pain, nausea, vomiting and diarrhoea.

Very rare (may affect up to 1 in 10,000 people):

  • Acute respiratory distress (signs include severe shortness of breath, fever, weakness and confusion).

Not known (frequency cannot be estimated from the available data):

  • Flu-like symptoms and feeling of general discomfort and illness
  • Generally feeling unwell (malaise)
  • Low levels of sodium in the blood (hyponatraemia)
  • Abnormal muscle breakdown (rhabdomyolysis) with symptoms such as muscle pain, weakness and swelling which can lead to kidney problems (urine can become dark)
  • Disturbed taste (dysgeusia)
  • Dose-related orthostatic effects such as lowering of blood pressure appearing when rising from a lying or sitting position
  • Cutaneous lupus erythematosus, which is identified by a rash that may appear on the face, neck, and scalp
  • Skin and lip cancer (non-melanoma skin cancer)
  • Decrease in vision or pain in your eyes due to high pressure (possible signs of fluid accumulation in the vascular layer of the eye (choroidal effusion) or acute angle-closure glaucoma).

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Losartan HCT tablets

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of that month.

Store below 25°C.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Losartan HCT tablets contain

  • The active substances are losartan potassium and hydrochlorothiazide.

    Each Losartan HCT 50mg/12.5mg tablet contains 50mg losartan potassium and 12.5mg hydrochlorothiazide.

    Each Losartan HCT 100mg/25mg tablet contains 100mg losartan potassium and 25mg hydrochlorothiazide.

  • The other ingredients are:

    Tablet core: mannitol (E421), microcrystalline cellulose, croscarmellose sodium, povidone (K-30), magnesium stearate.

    Film-coating: hypromellose (3cP, 50cP), hydroxypropylcellulose, titanium dioxide (E171), macrogol 400.

What Losartan HCT tablets look like and contents of the pack

Losartan potassium/Hydrochlorothiazide 50mg/12.5mg tablets are white to off-white coloured, 8 mm round shaped, biconvex, film-coated tablets, with breakline on both sides and debossed on one side with ’KK’ and ‘1’ on either side of breakline.

The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.

Losartan potassium/Hydrochlorothiazide 100mg/25mg tablets are white to off-white coloured, 10 mm round shaped, biconvex, film-coated tablets, with breakline on both sides and debossed on one side with ’KK’ and ‘3’ on either sides of breakline.

The tablet can be divided into equal doses.

Pack size

28 film-coated tablets.

Marketing Authorisation Holder

Accord, Barnstaple, EX32 8NS, UK

Manufacturer

Accord Healthcare Polska Sp.z.o.o.

Ul. Lutomierska 50, 95-200, Pabianice, Poland.

Or

Accord Healthcare B.V.

Winthontlaan 200, 3526KV Utrecht, The Netherlands

This leaflet was last revised in January 2025.

If you would like a leaflet with larger text, please contact 01271 385257.

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 00142/1165

Last revision stated in the text: January 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Losartan Potassium/hydrochlorothiazide 50/12.5 mg film-coated tablets

Prescription needed? Yes, prescription-only medicine (POM)
Active substances Losartan, Hydrochlorothiazide
Strength 50/12.5 mg
Pharmaceutical form Oral tablet
Losartan potassium/Hydrochlorothiazide 50mg/12.5mg Film-coated Tablets: White to off-white coloured, 8 mm round shaped, biconvex, film-coated tablets, with breakline on both sides and debossed on one side with ’KK’ and ‘1’ on either side of breakline
The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses.
How is it taken Oral
Excipients Mannitol (E421), Microcrystalline cellulose, Croscarmellose sodium, Povidone (K-30), Magnesium stearate, Hypromellose (3cP, 50cP), Hydroxypropylcellulose, Titanium dioxide (E171), Macrogol 400
Pack sizes 28 tablet
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 4 years
Storage Blister:
Store below 25°C.
Tablet container:
Store below 30°C.
Drug group (ATC) Angiotensin II antagonists and diuretics
  1. C Cardiovascular system drugs
    1. C09 Agents acting on the renin-angiotensin system
      1. C09D Angiotensin II receptor blockers (ARBs), combinations
        1. C09DA Angiotensin II receptor blockers (ARBs) and diuretics
          1. C09DA01 losartan and diuretics
Marketing authorisation PL 00142/1165 (first authorised 27 July 2010)
Marketing authorisation holder Accord-UK Ltd
Codes GTIN 5012617017307 · BNF 02050502

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.